Pen Needles - Global Market Trajectory & Analytics

Global Pen Needles Market to Reach $2.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Pen Needles estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 9.4% over the period 2020-2027. Standard Pen Needles, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Safety Pen Needles segment is readjusted to a revised 11.1% CAGR for the next 7-year period.



The U.S. Market is Estimated at $320.9 Million, While China is Forecast to Grow at 12.4% CAGR

The Pen Needles market in the U.S. is estimated at US$320.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$462.2 Million by the year 2027 trailing a CAGR of 12.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Select Competitors (Total 36 Featured):

• Allison Medical
• Artsana S.p.a.
• B. Braun Melsungen AG
• Becton
• Dickinson and Company
• HTL-STREFA S.A.
• Novo Nordisk A/S
• Owen Mumford
• Terumo Corporation
• UltiMed, Inc.
• Ypsomed Holding AG